Vol. 31.Issue. 3. May - June 2019 | Clínica e Investigación en Arteriosclerosis (English Edition)

ISSN: 2529-9123

Clínica e Investigación en Arteriosclerosis is the official journal of the Spanish Society of Arteriosclerosis, the Latinoamerican Society of Arteriosclerosis and the Iberolatinoamerican Society of Arteriosclerosis. The journal is the leading Spanish written peer-review journal in the field of arteriosclerosis and its related risk factors. The aim of the journal is primarily the promotion of knowledge and continued medical education, with a special focus in the Spanish-speaking audience, through the publication of relevant research contributions, basic and clinical, in the field and the publication of review and update articles.

See more Open Access Option

Clínica e Investigación en Arteriosclerosis has received its first journal Impact Factor (JCR) in 2023. Instructions for authors - Submit an article

"Methodological Notes": a new and important section in Clínica e Investigación en Arteriosclerosis

Indexed in:

Web of Science, Index Medicus/MEDLINE, Scopus, IBECS, IME, MEDES

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2022

1.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2022

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2022

0.36

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2022

0.605

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 31. Issue 3.

Pages 93-140 (May - June 2019)

Originals

A new rational approach to reach LDL-cholesterol concentration objectives after an acute coronary syndrome

Núria Ribas, Lluís Recasens, Silvia Pérez, Víctor Bazán, Juan Pedro-Botet, Sonia Ruiz, Roberto Elosua, Julio Martí-Almor

Clin Investig Arterioscler. 2019;31:93-100

Full text access

Open Article

Prevalence of erectile dysfunction in Spanish primary care setting and its association with cardiovascular risk factors and cardiovascular diseases. SIMETAP-ED study

Antonio Ruiz-García, Ezequiel Arranz-Martínez, Roberto Cabrera-Vèc)lez, David Palacios-Martínez, Montserrat Rivera-Teijido, Juan Carlos García-Álvarez, Luis Enrique Morales-Cobos, Juan Carlos Moreno-Fernández, ... on behalf of the Research Group of SIMETAP study

Clin Investig Arterioscler. 2019;31:101-10

Full text access

Open Article

Pharmacological PPARβ/δ activation upregulates VLDLR in hepatocytes

Mohammad Zarei, Emma Barroso, Xavier Palomer, Joan Carles Escolà-Gil, Lidia Cedó, Walter Wahli, Manuel Vázquez-Carrera

Clin Investig Arterioscler. 2019;31:111-8

Full text access

Open Article

Editorial

Treating dyslipidemia: something more than giving statins

Luis Masana

Clin Investig Arterioscler. 2019;31:119-20

Full text access

Open Article

Review article

Implications of the transcription factor WT1 linked to the pathologic cardiac remodeling post-myocardial infarction

Raúl Lelio Sanz, Luciana Mazzei, Walter Manucha

Clin Investig Arterioscler. 2019;31:121-7

Full text access

Open Article

Special article

Indications of PCSK9 inhibitors in clinical practice. Recommendations of the Spanish Society of Arteriosclerosis (SEA), 2019

Juan Francisco Ascaso, Fernando Civeira, Carlos Guijarro, José López Miranda, Luis Masana, José María Mostaza, Juan Pedro-Botet, Xavier Pintó, Pedro Valdivielso

Clin Investig Arterioscler. 2019;31:128-39

Open access

Open Article

Indexed in:

Follow us:

Subscribe:

Subscribe to our newsletter